Role of immunohistochemical p53 expression as a prognostic marker in molar pregnancy
Bioinformation · 31.07.2026 · 22 (7) · 4230-4233
DOI: 10.6026/973206300224230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.07.2026. Verfasst von Tasrina Akter.
Abstract (Originalsprache)
Malignant transformation of hydatidiform mole remains difficult to predict using conventional clinical parameters alone. A cross sectional analytical study of 50 women showed significantly higher p53 expression in cases with elevated β-hCG levels and subsequent malignant progression. ROC analysis showed excellent predictive performance (AUC=0.938), with 87.5% sensitivity and 71.3% specificity at a 42.5% stained-cell cut-off. All patients with malignant progression showed positive p53 staining (p=0.018). Thus, data shows p53 immunoexpression as a promising prognostic biomarker for early risk stratification and clinical management of molar pregnancy.
Zitieren
APA
Akter, T. (2026). Role of immunohistochemical p53 expression as a prognostic marker in molar pregnancy. Bioinformation, 22(7), 4230-4233. https://doi.org/10.6026/973206300224230
Vancouver
Akter T. Role of immunohistochemical p53 expression as a prognostic marker in molar pregnancy. Bioinformation. 2026;22(7):4230-4233. doi:10.6026/973206300224230
BibTeX
@article{Akter2026,
author = {Akter, Tasrina},
title = {Role of immunohistochemical p53 expression as a prognostic marker in molar pregnancy},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {7},
pages = {4230--4233},
doi = {10.6026/973206300224230}
}
EUVIMED